<DOC>
	<DOCNO>NCT01215513</DOCNO>
	<brief_summary>This open-label , multi-centre single arm trial investigate long-term safety tolerability degarelix Korean patient prostate cancer .</brief_summary>
	<brief_title>Long-Term Safety Tolerability Degarelix One-Month Dosing Regimen Korean Patients</brief_title>
	<detailed_description />
	<criteria>Has give write informed consent trialrelated activity perform . A trialrelated activity define procedure would perform normal management patient Has complete 7month main trial , FE200486 CS42 Has withdrawn/discontinued FE200486 CS42 trial A patient may also enter CS42A trial discretion investigator due safety lack efficacy concern ( LH PSA response ) CS42 trial .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>